VanEck Biotech ETF (BBH) |
| 229.3922 0.756 (0.33%) 09-11 16:00 |
| Open: | 229.99 |
| High: | 230.875 |
| Low: | 228.945 |
| Volume: | 2,743 |
| Market Cap: | 442(M) |
| PE Ratio: | 28.5 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 285.40 |
| Resistance 1: | 244.35 |
| Pivot price: | 238.11 |
| Support 1: | 224.86 |
| Support 2: | 212.81 |
| 52w High: | 244.35 |
| 52w Low: | 160.91 |
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 28 Aug 2026
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? - The Motley Fool
Mon, 24 Aug 2026
BBH: Biotech’s Next Growth Cycle Is Just Getting Started (NASDAQ:BBH) - Seeking Alpha
Mon, 24 Aug 2026
VanEck Biotech ETF (BBH) is a Buy with strong g... - pluang.com
Sat, 22 Aug 2026
Biotech ETF Showdown: Why a 251-Stock Basket Is Beating Concentrated Rivals - finance.biggo.com
Thu, 20 Aug 2026
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - The Motley Fool
Wed, 05 Aug 2026
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
